Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies
泽布替尼用于治疗伴有del(17p)和/或TP53 CLL/SLL的患者：临床研究分析
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025015986
Tam, Constantine S; Anderson, Mary Ann; Šimkovič, Martin; Ghia, Paolo; Flinn, Ian W; Laribi, Kamel; Opat, Stephen; Cull, Gavin; Munir, Talha; Österborg, Anders; Tedeschi, Alessandra; Wang, Megan; Szeto, Andy; Allewelt, Heather; Salmi, Tommi; Li, Jessica; Xu, Linlin; Wu, Kenneth; Vezan, Remus; Shadman, Mazyar; Brown, Jennifer R
